Table 1:

Characteristics of patients with CAA

Patient Characteristicn = 50
Probable CAA, n (%)43 (86.0)
Biopsy proved, n (%)12 (24.0)
Possible CAA, n (%)7 (14.0)
Neurologic outcomes
    Ischemic stroke, n (%)35 (70.0)
    Hemorrhage, n (%)23 (46.0)
    Both, n (%)19 (38.0)
VWE29 (58.0)
Clinical confounders
    Maximum percent stenosis, mean (SD)14.9 (20.8)
    Age, mean (SD), y71.9 (7.7)
    Female sex, n (%)27 (54.0)
    Hypertension, n (%)43 (86.0)
    Hyperlipidemia, n (%)32 (64.0)
    Diabetes, n (%)14 (28.0)
    Smoking, n (%)19 (38.0)
    Antiplatelet, n (%)18 (36.0)
    Anticoagulation, n (%)5 (10.0)
    Antihypertension, n (%)37 (74.0)
    Statin, n (%)27 (54.0)
    Time between symptom onset and MR imaging in days, mean (SD)3.9 (2.6)
    Inflammatory marker elevation, n (%), n = 30 available10 (33.3)